Cover image: A view of Altria's booth from the entrance at NACS Show 2026. Large graphics on either side of the entrance feature Marlboro, Black & Mild, on! PLUS and NJOY product packaging. No clearly identifiable warning statement is visible on the large promotional graphics shown.Photo: 2Firsts, NACS Show 2026.
Key Points
On-site reporting: 2Firsts documented Altria's product displays at NACS Show 2026, with published photographs subsequently prompting questions about advertising warning compliance.
Former FDA official's concerns: Gabriel Muniz raised a conditional concern that advertising shown in the original report's main photograph could violate warning requirements if a compliant statement was absent.
Altria's response: The company said its booth communications were B2B, directed at retailers and wholesalers, and complied with all applicable laws.
Independent legal analysis: Regulatory lawyer Azim Chowdhury told 2Firsts that federal warning rules for e-cigarettes and nicotine pouches provide no general B2B trade-show exemption. Covered visual advertisements must devote at least 20% of their area to the required warning.
Regulatory implications: Different tobacco and nicotine categories face distinct warning requirements, raising questions about which trade-show displays qualify as advertising and how the rules apply.
2Firsts,
November 4, 2026
Altria's tobacco and nicotine product displays at the 2026 NACS Show in Las Vegas have prompted questions about federal advertising warning requirements at industry trade events. The company says its booth communications were business-to-business and complied with applicable laws, while a U.S. tobacco regulatory lawyer consulted by 2Firsts says federal warning rules for e-cigarettes and nicotine pouches provide no general exemption for B2B trade shows.
The questions emerged after 2Firsts published photographs of Altria's exhibition booth and a former Food and Drug Administration (FDA) official raised concerns about whether advertising visible in the photographs carried the required tobacco product warnings.
Altria's Displays Draw Questions About Advertising Warnings
The NACS Show, held October 7–9 at the Las Vegas Convention Center, brought together convenience retailers, manufacturers and suppliers.
As 2Firsts reported from the show, Altria's booth featured Marlboro cigarettes, Black & Mild cigars, on! nicotine pouches, NJOY e-cigarettes and Ploom heated-tobacco products, alongside non-nicotine energy brands RIOT Energy and Proper Wild.
A large exterior display showed enlarged images of Marlboro, Black & Mild, on! PLUS and NJOY product packaging. Inside the booth were separate displays for nicotine pouches and NJOY products, as well as panels presenting convenience-store shopping figures associated with Altria's operating companies.
Photographs taken by 2Firsts showed nicotine warning statements on NJOY packaging. A warning statement was also visible above the on! product display.
2Firsts encountered different photography instructions during two visits. On an earlier day, its journalist photographed and filmed without objection. On the exhibition's final day, however, an entrance staff member said photography and video recording were prohibited under Altria's policy. Asked why filming had previously been allowed, the staff member suggested the restriction might not have been communicated during the earlier visit.
After the journalist presented media credentials, a company communications representative arranged access and permitted photography and filming.
In a subsequent email to 2Firsts, Dena Potter, a senior communications manager at Altria, described the interruption as part of the company's media reception procedure, intended to ensure that a spokesperson was available to assist visiting journalists. She said accredited media were welcome to photograph and film inside the booth.
Following a LinkedIn post by 2Firsts co-founder Alan Zhao, Gabriel Muniz, a former FDA official who served as a supervisory consumer safety officer in the agency's tobacco operations program, raised a separate question about advertising warnings.
Referring specifically to the main photograph accompanying the original 2Firsts report, Muniz questioned whether the advertising displayed at the event included the required warning statement, citing 21 CFR Part 1143 and Section 903(a)(7)(B) of the Federal Food, Drug, and Cosmetic Act.
Muniz recalled conducting undercover investigations at similar events while working for the FDA. He said photographs of advertisements, promotional materials and product displays were preserved as evidence and could, where appropriate, support regulatory citations or FDA warning letters.
He added that if the photograph accurately represented the advertisement as displayed, and no compliant warning appeared elsewhere on it, the image could provide evidence of a potential violation.
Altria Says Its Booth Communications Complied With Applicable Laws
Following the discussion, 2Firsts contacted Altria to clarify its photography policy and the application of advertising warning requirements to its exhibition materials.
Potter subsequently provided a statement that she authorized 2Firsts to attribute to her as a company spokesperson.
"The NACS Show is a trade event for retailers and wholesalers, not consumers," Potter said.
She added: "Accordingly, our booth content and communications are business-to-business in nature and comply with all applicable legal requirements, consistent with those of other manufacturers exhibiting at NACS and similar trade events."
"We take great care to achieve warnings compliance for all consumer facing communications," she said.
The statement did not specify whether Altria classified particular exterior product graphics as tobacco advertisements or where any warnings applicable to those graphics were displayed.
U.S. Warning Rules Provide No General B2B Exemption, Lawyer Says
To examine the federal regulatory framework, 2Firsts separately contacted Azim Chowdhury, a partner at Washington-based law firm Keller and Heckman LLP whose practice includes FDA tobacco and nicotine regulation.
Chowdhury provided a written explanation of the general warning requirements, focusing on electronic nicotine delivery systems (ENDS) and nicotine pouches.
He identified 21 CFR §1143.3 as the principal regulation governing warning statements for these products. Advertisements for covered products must include:
"WARNING: This product contains nicotine. Nicotine is an addictive chemical."
The regulation requires each applicable advertisement to bear the warning and does not distinguish between advertising directed at consumers and advertising directed at retailers or wholesalers, Chowdhury explained.
"I am not aware of any exemption in the regulation, or in FDA guidance, simply because the advertisement appears at a B2B or adult-only trade show," he told 2Firsts.
He added that provisions limiting retailers' responsibility for advertising they do not control do not create a general exemption for manufacturers or distributors.
Under §1143.3, warnings on covered visual advertisements must appear in the upper portion and occupy at least 20% of the advertisement's area. Additional requirements govern typography, contrast and borders. The FDA describes these standards on its Advertising and Promotion webpage.
Whether exhibition materials qualify as advertising is a separate question.
Chowdhury noted that Part 1143 does not define "advertisement," although the FDA has interpreted the term broadly. In his view, large product images, branded booth panels, banners and digital displays used to promote tobacco products would generally qualify as advertising, even without prices or explicit invitations to purchase.
Displaying actual packaged products bearing their own warnings, or signs identifying a company solely by name, may raise different questions depending on the content and overall presentation.
Chowdhury also distinguished packaging warnings from advertising warnings. A warning printed on a product package, or visible within an enlarged image of that package, does not automatically satisfy the separate advertising requirements. Nor would a standalone warning elsewhere in a booth generally suffice.
Each applicable advertisement must incorporate a warning that meets the required placement and format standards.
Different Products, Different Warning Requirements
The legal framework differs across tobacco categories. Cigarettes and traditional smokeless tobacco are governed by separate federal warning statutes, including 15 U.S.C. §1333 and 15 U.S.C. §4402.
The FDA's newer graphic cigarette warning rule has faced legal challenges and remains blocked by court orders, while warning requirements for cigars and pipe tobacco adopted under the agency's deeming rule were vacated by a federal court.
Chowdhury said these distinctions arise from product-specific laws rather than a general exemption for professional trade shows.
The questions come as nicotine use patterns in the United States continue to change. According to an August 2026 report from the National Institutes of Health, past-year nicotine pouch use among surveyed U.S. adults aged 19–65 more than doubled between 2023 and 2025. Nicotine vaping remained high among young adults, while cigarette smoking rates were comparatively low.
As e-cigarettes, nicotine pouches and conventional tobacco products increasingly share retail and exhibition spaces, manufacturers must navigate warning requirements that differ by product category. Trade shows add another consideration: promotional materials are presented to professional buyers, but federal advertising obligations for covered products do not automatically change with the audience.
The questions raised at NACS extend beyond Altria's booth. They concern not only how existing warning requirements apply to product displays and promotional materials, but also whether the current product-specific framework adequately addresses the growing range of nicotine products and advertising formats.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
